Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Transaction in Own Shares

24 Nov 2025 07:00

RNS Number : 6290I
B.P. Marsh & Partners PLC
24 November 2025
Β 

24 November 2025

Β 

B.P. Marsh & Partners Plc

Β 

("B.P. Marsh" or the "Company")

Β 

Purchase of Own Shares and Total Voting Rights

Β 

In accordance with the Company's Share Buyback programme, as outlined in its announcement onΒ 17 April 2025, B.P. Marsh announces that it has purchased 4,000 of its ordinary shares ("Shares") at a price ofΒ 657.00p penceΒ per Share. The purchased Shares will be held inΒ Treasury.

Β 

Aggregated information

Β 

Date of Purchase

21 November 2025

Number of shares purchased

4,000

Higher Price paid per share

657.00p

Lowest Price paid per share

657.00p

Volume Weighted Average price paid

657.00p

Β 

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation)Β (which forms part of domesticΒ UKΒ law pursuant to theΒ European UnionΒ (Withdrawal) Act 2018), a detailed breakdown of individual trades is available below:

Β 

Number of Shares purchased

Transaction price (GBp)

Time of transaction

Trading venue

4,000

657.00p

12:13:15

AIMX

Β 

Total voting rights

Following the purchase, the Company's total issued share capital consists of 37,100,000 Shares and the Company holds 1,034,000 Shares in treasury and therefore, the total number of Shares carrying voting rights in the Company is 36,066,000.

Β 

The above figure of 36,066,000 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under theΒ FCA'sΒ Disclosure Guidance and Transparency Rules.

Β 

For further information on B.P. Marsh, its strategy and current portfolio, please visitΒ www.bpmarsh.co.ukΒ or contact:Β 

Β 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

Β 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker

Panmure Liberum Limited

Atholl TweedieΒ /Β Amrit MahbubaniΒ /Β David Watkins

Β 

+44 (0)20 7886 2500

Joint Corporate Broker

Singer Capital Markets Advisory LLP

Charles Leigh PembertonΒ /Β Asha Chotai

Β 

+44 (0)20 7496 3000

Financial PR & Investor Relations

Tavistock

bpmarsh@tavistock.co.uk

Simon HudsonΒ /Β Katie Hopkins /Β Kuba Stawiski

Β 

+44 (0)20Β 7920 3150

Β 

-Ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSXXLFLEFLXFBD
Date   Source Headline
28th Oct 20107:00 amRNSHalf Yearly Report
24th Sep 20107:00 amRNSNotice of Interim Results
22nd Jul 20102:23 pmRNSCompletion of U.S. Risk (UK) Limited Investment
21st Jul 201012:28 pmRNSResult of AGM
22nd Jun 20109:35 amRNSReplacement - Notice of Annual General Meeting
22nd Jun 20107:00 amRNSNotice of Annual General Meeting
10th Jun 201011:05 amRNSReplacement - Investment in U.S. Risk (UK) Limited
10th Jun 20107:00 amRNSInvestment in U.S. Risk (UK) Limited
9th Jun 20103:22 pmRNSDirectors' Loan
2nd Jun 20107:00 amRNSFinal Results
7th May 20107:00 amRNSNotice of Final Results
21st Jan 20107:00 amRNSDisposal
21st Jan 20107:00 amRNSAcquisition
11th Jan 201012:25 pmRNSDirector's Dealing
14th Dec 200910:16 amRNSDirector's Dealing
27th Oct 20097:00 amRNSInterim Results
26th Oct 20093:26 pmRNSHolding(s) in Company
30th Sep 20097:00 amRNSNotice of Interim Results
23rd Jul 200910:41 amRNSAnnual Report and Accounts
21st Jul 20097:00 amRNSResult of AGM
18th Jun 20094:07 pmRNSNotice of AGM
9th Jun 20099:28 amRNSInvestee Company, Hyperion, Announces Acquisition
3rd Jun 20097:00 amRNSLoans to Investee Company
3rd Jun 20097:00 amRNSFinal Results
18th May 20099:52 amRNSChange of Adviser
6th May 200910:58 amRNSNotice of Results
6th Apr 20093:40 pmRNSHolding(s) in Company
26th Mar 200910:11 amRNSHolding of Shares by a Director
2nd Feb 20097:00 amRNSDirectorate Change
9th Dec 20084:23 pmRNSDirector/PDMR Shareholding
4th Dec 20083:26 pmRNSDirectorate Change
3rd Dec 20084:53 pmRNSDirector/PDMR Shareholding
1st Dec 20083:05 pmRNSChange of Registered Office
18th Nov 20083:06 pmRNSDirector/PDMR Shareholding
12th Nov 200812:42 pmRNSDirector/PDMR Shareholding
28th Oct 20087:00 amRNSInterim Results
6th Oct 20082:16 pmRNSNotice of Interim Results
1st Oct 20087:00 amRNSAppointment of Nominated Adviser
24th Jul 20082:24 pmRNSResult of AGM
25th Jun 20087:00 amRNSNotice of AGM
5th Jun 20087:00 amRNSFinal Results
7th May 20082:33 pmRNSNotice of Results
2nd Apr 20089:05 amRNSHyperion partners with 3i
20th Mar 20087:00 amRNSInvestment in Trillium
11th Mar 20087:01 amRNSInvestment in Business Broker
25th Feb 20084:17 pmRNSDirectorate Change
14th Feb 20081:26 pmRNSFurther re: Disposal
12th Feb 20087:01 amRNSDisposal
4th Feb 20082:46 pmRNSIncreased Investment in Summa
27th Nov 20077:01 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.